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Abstract
Background: Less is known about mass drug administration [MDA] for neglected tropical diseases [NTDs] than is
suggested by those so vigorously promoting expansion of the approach. This paper fills an important gap: it draws
upon local level research to examine the roll out of treatment for two NTDs, schistosomiasis and soil-transmitted
helminths, in Uganda.
Methods: Ethnographic research was undertaken over a period of four years between 2005-2009 in north-west
and south-east Uganda. In addition to participant observation, survey data recording self-reported take-up of drugs
for schistosomiasis, soil-transmitted helminths and, where relevant, lymphatic filariasis and onchocerciasis was
collected from a random sample of at least 10% of households at study locations. Data recording the take-up of
drugs in Ministry of Health registers for NTDs were analysed in the light of these ethnographic and social survey
data.
Results: The comparative analysis of the take-up of drugs among adults revealed that although most long term
residents have been offered treatment at least once since 2004, the actual take up of drugs for schistosomiasis and
soil-transmitted helminths varies considerably from one district to another and often also within districts. The
specific reasons why MDA succeeds in some locations and falters in others relates to local dynamics. Issues such as
population movement across borders, changing food supply, relations between drug distributors and targeted
groups, rumours and conspiracy theories about the ‘real’ purpose of treatment, subjective experiences of side
effects from treatment, alternative understandings of affliction, responses to social control measures and historical
experiences of public health control measures, can all make a huge difference. The paper highlights the need to
adapt MDA to local circumstances. It also points to specific generalisable issues, notably with respect to health
education, drug distribution and more effective use of existing public health legislation.
Conclusion: While it has been an achievement to have offered free drugs to so many adults, current standard
practices of monitoring, evaluation and delivery of MDA for NTDs are inconsistent and inadequate. Efforts to
integrate programmes have exacerbated the difficulties. Improved assessment of what is really happening on the
ground will be an essential step in achieving long-term overall reduction of the NTD burden for impoverished
communities.
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Introduction
Global aspirations to achieve the Millennium Develop-
ment Goals by ‘making poverty history’ and alleviating
the suffering of ‘the bottom billion’ has generated
unprecedented attention on a range of predominantly
parasitic and bacterial infections endemic in large parts
of sub-Saharan Africa. These infections cause significant
morbidity, if not mortality, among politically and eco-
nomically marginal populations They are increasingly
grouped together and referred to as ‘neglected tropical
diseases’ [NTDs]; and substantial funding and a range of
medicines have become available from international
agencies and pharmaceutical companies to support the
design and implementation of national programmes
seeking to control them. All programmes involve the
mass distribution of drugs, free of charge, to adults and
children living in areas where the diseases are endemic.
A great deal of optimism surrounds mass drug admin-
istration [MDA] programmes. Numerous publications
emphasise their potential to alleviate sickness and suffer-
ing (see, for example, Brady et al [1]; Engel et al [2]; Fen-
wick et al [3]; Fenwick [4]; Molyneux et al [5]; Molyneux
et al [6]; Manderson et al [7]; Hotez [8]; Hotez et al [9])
and the majority of reported results are presented in a
positive light (see, for example, Kabatereine et al [10];
Kabatereine et al [11]; Knopp et al [12]; Standley et al
[13]; Yu et al [14].) In its first major report on NTDs,
published in 2010, the Director-General of the World
Health Organisation claims that nearly 670 million peo-
ple had been reached with preventive chemotherapy by
the end of 2008. She maintains that aiming at complete
control of NTDs is fully justified, and that there is a ‘pos-
sibility that several of these ancient diseases could be
eliminated by 2020’ if current efforts to scale up interven-
tions are increased [[15]:v].
There are, however, a number of academics who have
expressed concern about the way in which MDA for
NTDs is being implemented. For example, Katabarawa
et al [16]; Katabarwa and Richard [17]; Amazigo et al
[18] and Parker et al [19] have documented the hazards
of relying upon unpaid volunteers to distribute drugs
within designated communities, while Gryseels et al
[20], and Coulibaly et al [21] suggest that vertical sys-
tems of drug administration run the risk of overwhelm-
ing fragile health-care delivery mechanisms. In addition,
Utzinger et al [22] questions the sustainability of control
programmes that rely so heavily upon preventive che-
motherapy; and Kolaczinski et al [23], aware of the
rhetoric surrounding the benefits of MDA control pro-
grammes, calls for a more adequate evidence base. The
article also draws attention to the point that current
endeavours to ‘integrate’ vertical control programmes
may lead to the development of a parallel health-
delivery system, with potentially serious consequences
for ministries of health. A rather different issue has
been highlighted by the work of Parker et al [19]:
namely, that it is hazardous to assume that targeted
populations will necessarily understand or agree with
the rationale for MDA. Indeed, they may actively resist
treatment. This can have negative ramifications, not
only for the control of NTDs, but also for other infec-
tious disease control programmes. Finally, Danso-
Appiah et al [24], Lammie et al [25], Fenwick [4] and
Gryseels [26] have highlighted limits in knowledge sur-
rounding the safety and efficacy of combining drugs for
some NTDs, with Gryseels taking the argument a step
further and raising concerns about possible drug resis-
tance if mass treatment becomes long term.
The literature highlighting reservations about NTD
programmes is not cohesive. Indeed, some of the
authors cited above fundamentally disagree with each
others’ interpretations of the available evidence - most
notably on the issue of drug resistance (see, for example,
Gryseels [26] and Tchuente et al [27]. Also, in spite of
their doubts, most remain very committed to the idea of
MDA for NTD control. Nevertheless, taken together,
the insights and arguments they present raise important
questions about current approaches. Although the point
is not always made explicit, there is an underlying
recognition that some assessments have been shaped by
the need to raise and sustain large amounts of funding,
and have been overly positive. Such exaggerations may
prove counter-productive.
A danger now is that there will be a backlash, and that
genuine achievements will be overlooked: a point that
has been made recently by Narcis Kabatereine, Uganda’s
head of vector control. He has dedicated his working
life to the control of schistosomiasis, is a co-author of
several of the papers cited above and below extolling
the virtues of MDA, and has been hailed as the ‘unsung
hero of neglected tropical diseases’ for his dedication
and commitment to the cause [28]. However, he has
become worried about the way in which external fund-
ing from the United States Agency for International
Development [USAID], channelled through the Ameri-
can organisation RTI International, is hindering the
development of a fully-integrated national control pro-
gramme for NTDs. Instead, USAID are developing a
separately funded, parallel structure located within the
Ministry of Health. In a recent interview he has gone so
far as to not only draw attention to our own findings
that suggest that recent efforts to control schistosomia-
sis have faced problems [19], but also to express the
view that current approaches prohibit addressing diffi-
culties with the roll out of MDA and that this could
well have a negative impact on drug uptake in the future
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[28]. His concerns are reflected in a carefully worded
paper which he has co-authored with colleagues
involved in the establishment of integrated control
programmes in Southern Sudan, Mozambique and
Tanzania [29].
The findings presented in this paper explore these
issues. Drawing on local level research undertaken in
Uganda since 2005, it shows that NTDs can potentially
be controlled by MDA, but not all that has been claimed
about successful treatment coverage is based on robust
evidence. The problems arising on the ground are often
acute. The paper goes on to suggest that a change in
direction is required if targets are to be met and reduc-
tions in NTD prevalence maintained. Among other
things, it demonstrates the need for more appropriate
methods of drug delivery, improved communication
with target populations, and a more rigorous approach
to monitoring. Insights derived from fieldwork at a vari-
ety of locations spread across Uganda demonstrate how
lessons could be learned. Comparative results from simi-
lar research carried out in Tanzania are briefly reviewed
in the conclusion.
Uganda is an interesting and important place to
explore social responses to MDA, not least because it
was the first country to establish national control pro-
grammes for the control of NTDs. More specifically,
national control programmes were established for onch-
ocerciasis, lymphatic filariasis, schistosomiasis and soil-
transmitted helminths in the early part of 2000. The
desire to integrate programmes and thereby avoid the
unnecessary duplication of resources led to the estab-
lishment of the National Control Programme for the
Integrated Control of Neglected Tropical Diseases in
Uganda in 2007. Since then, in areas of co-endemicity,
endeavours have been made to deliver free treatment for
onchocerciasis, schistosomiasis, lymphatic filariasis and
soil-transmitted helminths simultaneously.
Recent assessments of MDA for schistosomiasis
and soil-transmitted helminths in Uganda
As elsewhere, published epidemiological and parasitolo-
gical research on Uganda suggests that mass treatment
has successfully reduced the prevalence and intensity of
infection, as well as clinical indicators of morbidity
among school children in targeted areas [10,11]. How-
ever, there are limitations with this type of work.
Kabatereine et al’s research [11], for example, attempted
to monitor cohorts of children that had received annual
rounds of praziquantel (for the treatment of schistoso-
miasis) and albendazole (for the treatment of soil-
transmitted helminths). Follow up visits occurred six
months after each round of treatment and every time a
positive case was detected, additional treatment was
provided. As a result, the cohort studies provide a
picture of what happens when treatment is made avail-
able at six monthly intervals. They do not capture the
experiences of children that are treated at 12 monthly
intervals by control programmes, nor do they shed light
on the proportion of school-aged children that receive
multiple rounds of treatment. This is unfortunate as the
number of children successfully completing primary
school in under-resourced, rural areas is often small, a
point underlined by the large number of children that
have dropped out of cohort studies. Thus, cohort studies
are biased towards children from families of long-term
and stable residency who are known to receive multiple
rounds of treatment.
Research undertaken by Brooker et al [30] also leaves
some important questions unanswered. This cross-sec-
tional study used the Lot Quality Assurance Sampling
(LQAS) technique to map the prevalence of Schistosoma
mansoni among school children in four different regions
in Uganda, before and after several rounds of mass
treatment in 2003 and 2006 respectively. Working with
four teams of three technicians, they sampled an average
of 8 schools a day for 3 days in Eastern, Central, North-
ern and Western regions of Uganda. Fifteen school chil-
dren were randomly selected from each school; and the
prevalence of S.mansoni was deemed to be low if 2 or
less children tested positive for S.mansoni and high if 7
or more children tested positive for S.mansoni. GPS
readings for each school were also recorded and this
allowed the creation of prevalence maps using GIS soft-
ware. The results are visually impressive and have fed
into the general optimism about the ‘magic bullet’ nat-
ure of NTD control. However, extrapolating from such
a small sample is problematic, especially as other data
collected at schools in some of the sampled districts
suggests that levels of re-infection are high. For exam-
ple, rates of re-infection among school children were
recently reported to be 54%, 84% and 60% at Panyimur
Primary School, Nyakagei Primary School and Boro Pri-
mary School in Panyimur sub-county, Nebbi district
(Schistosomiasis Control Initiative [SCI] Country Pro-
gramme Manger, personal communication, 2008). In
short, the suggestion on the SCI website (http://www.
imperial.ac.uk/schisto, accessed on November 15th 2008)
that the rapid mapping exercise illustrates that there is a
“realistic chance of bringing bilharzia infection in
Uganda to below an intensity level at which it is a major
public health problem” is surely open to question.
In addition to epidemiological and geographical sur-
veillance data exploring the impact of MDA for school-
children in Uganda, endeavours have been made by
Lubanga [31] and Fleming et al [32] to monitor social
responses to MDA among adults in Uganda. The type
of research undertaken by Lubanga is often referred to
as ‘qualitative research’ or a ‘knowledge, attitudes and
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practice (KAP) survey’, while Fleming et al [32] refer to
their work as ‘process monitoring’. Useful insights may
emerge from this type of work, but a persistent problem
with both approaches is that findings from semi-struc-
tured questionnaires, focus group meetings and key
informant interviews are stripped of their political and
social context and presented as a series of disembodied
quotes. More often than not, they are taken as unpro-
blematic statements that reveal the ‘true’ state of play,
and no attempt is made to corroborate ideas with infor-
mation derived from other methods or data sources.
Lubanga’s research, for example, explores social
responses to MDA in Nebbi and Busia districts, Uganda.
It presents a series of quotes derived from focus groups
and interviews to suggest generally successful drug take-
up and even a growing demand for treatment. No
attempt is made to explore the generalisability of find-
ings by undertaking surveys of drug uptake among tar-
geted populations in the selected districts; or to analyse
the data in relation to quantitative information monitor-
ing the take-up of drugs in Ministry of Health registers;
or to observe what actually happens when drugs are dis-
tributed at a local level. As a result, it is not possible to
know if those stating that they had received drugs had
actually swallowed them, or if perspectives differed sig-
nificantly between research sites. Nevertheless, the infor-
mation presented in Lubanga’s report was subsequently
used as evidence in the article published by Fleming
et al [32]. Here, findings from Lubanga’s KAP survey are
uncritically combined with data documenting the total
number of drugs sent out from Kampala. Again, the
paper does not discuss how the drugs were actually dis-
tributed between and within districts; or whether or not
they were swallowed, in whole or part, by targeted peo-
ple once they had been distributed at a village level. It
may be that the positive assessment of MDA presented
in this paper is correct, but it is not really possible to
come to such a conclusion from the findings presented.
However, limitations in the work cited above are rela-
tively minor compared to USAID funded assessments by
RTI International. Monitoring undertaken since 2008
suggests, for example, that USAID/RTI endeavours to
take primary responsibility for the roll out of mass treat-
ment for NTDs has been extremely successful. That is,
the NTD Control Programme had provided, by the third
year of the programme, 27,656,133 treatments to
13,687,841 people in 72 districts within Uganda (http://
ntd.rti.org, accessed on 28th September 2010.) A map is
also shown on the RTI website to convey a sense of a
hugely successful programme; and links are provided to
reports describing the achievements of community drug
distributors and treatment programmes in formerly war-
affected parts of the country. Precisely how these facts
were collected is not made clear, but from our own
observations and discussions with staff in the field, they
appear to be derived from short questionnaires carried
out on a small number of people at selected districts,
combined with records relating to the overall numbers
of tablets sent out from the national headquarters.
There is no indication to suggest that any effort was
made to look beneath the surface and to see how stated
practice related to actual behaviour. The absence of cri-
tical discussion of findings and the way in which they
have been presented suggests that the primary purpose
is to ‘prove’ the on-going success of the programme
with a view to justifying the next round of USAID
funding.
In short, biomedically-orientated and programme-
linked assessments have, to date, focused on children
rather than adults and while some of the findings emer-
ging from this type of work in Uganda are interesting,
they leave the following questions unanswered: What
proportion of adults living in endemic areas are receiv-
ing drugs from MDA programmes on an annual basis?
How are these free drugs perceived? Are they being
swallowed? Do local understandings of the aetiology and
treatment of ‘NTDs’ influence the consumption of
drugs? Are there any indications to suggest that adults
are becoming aware of the benefits of treatment? These
are important questions to address as the success of the
National Control Programme ultimately depends upon
adults appreciating the benefits of treatment to a point
where they become willing to purchase the drugs for
themselves and their children when free treatment
comes to an end.1 As indicated above, a small amount
of research exploring social responses to MDA among
adults has purported to answer some of these questions,
but the historical, political, economic and social context
of treatment has been ignored, and findings are neither
assessed critically nor adequately triangulated.
The research presented here attempts to reverse this
trend. It builds upon the article by Parker et al [19],
which raised serious concerns about MDA based on
findings from two districts. Key points are updated in
this paper and compared with results from other parts
of Uganda. It is demonstrated that, while the pro-
gramme for the Integrated Control of Neglected Tropi-
cal Diseases has a clear protocol for rolling out drugs in
similar ways across the country, in practice distribution
varies considerably from place to place. A range of fac-
tors at a local, national and international level affect the
uptake of drugs between and within districts, and even
within villages. These findings have wide-ranging impli-
cations, not only for those committed to the control of
NTDs in Uganda and other parts of East Africa, but
also for furthering our understanding of the role public
policy can play in alleviating sickness and poverty more
generally.
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Fieldsites
Research took place in three districts in north-western
Uganda and two districts in south-eastern Uganda. In
north-western Uganda, the selected districts were Nebbi,
Moyo and Adjumani (which formerly comprised part of
Moyo district). Nebbi district shares a border with the
Democratic Republic of Congo, while Moyo and Adju-
mani districts share their northern borders with Sudan.
In south-eastern Uganda, research was undertaken in
Busia and Bugiri districts. Busia district shares a border
with Kenya, while Bugiri district borders Busia. Both dis-
tricts have villages located on the shores of Lake Vic-
toria. The populations inhabiting these five districts
have all been influenced, in different ways, by the chan-
ging political and economic landscape of Uganda.
Indeed, MDA is occurring in places that could not be
more different from each other and, as will be explained
below, that is one reason why take up has varied so
dramatically.
Methods
Fieldwork took place over a period of four years
between 2005 and 2009. At all field sites, research
focussed on the roll out of MDA for schistosomiasis
and soil-transmitted helminths and, where relevant, lym-
phatic filariasis and onchocerciasis.2 While the research
methods at these sites involved looking at all kinds of
available evidence, particular weight was given to the
following: (1) assessments of the local context in which
MDA is occurring, including historical factors and the
current political and economic situation; (2) data
recording the names and number of adults in Ministry
of Health registers who were reported to have received
drugs for schistosomiasis, soil-transmitted helminths
and, if appropriate, lymphatic filariasis and onchocercia-
sis; (3) observations of MDA as it occurred; and (4) sur-
vey data (involving a random sample of at least 10% of
households at each location) recording the proportion of
adults who reported having been given the opportunity
to receive and swallow drugs for the treatment of schis-
tosomiasis and soil-transmitted helminths and, where
relevant, lymphatic filariasis and onchocerciasis. In addi-
tion, (5) open-ended and semi-structured interviews
were undertaken with those involved in or affected by
MDA, including political figureheads, religious leaders,
local healers (spirit mediums, herbalists), fisherman,
market women and farmers. In short, every effort was
made to triangulate information and to use a variety of
methods to cross-check results.3
Inevitably, there were some variations in the meth-
ods employed between sites, notably with respect to
the use of registers. In some placers, these were
found to have been lost or were so poorly kept as to
be almost useless. In other places, notably Nebbi dis-
trict from 2004-2005, the data recorded was detailed
and proved to be accurate when cross-checked with
survey information on drug take-up. Variations in
data used between sites are detailed in the sub-
sections below.
Methods in Panyimur sub-county, Nebbi District
A total of 7 months fieldwork was undertaken In Panyi-
mur, Nebbi district between May 2005 and September
2008. This was the first research site, and the most
intensively studied. In 2005, participant observation,
open-ended, unstructured interviews and semi-
structured interviews were undertaken over a period of
four months, and full details of this research have been
published by Parker et al [19]. Further research was
undertaken from July to September 2008, with the assis-
tance of four MSc students from the London School of
Economics and five locally-trained researchers, three of
whom assisted with the research in 2005.
In common with the research undertaken in 2005, a
variety of methods were drawn upon to explore local
responses to mass treatment in 2008. These include the
following: participant observation in Panyimur Trading
Centre; 50 open-ended, unstructured interviews and 10
focus group discussions with district officials, local
council officers, teachers, healers, politicians, market
traders and groups of migrants. Semi-structured inter-
views were also undertaken in 15 of the 49 villages that
constitute Panyimur sub-county. These interviews
occurred with a 10% random sample of adults that were
registered by staff from the Ministry of Health in MDA
treatment registers in 2004; and they were selected to
assess, among other things, the proportion of people
that had been re-treated in 2007, compared to 2004
and 2005.
In addition, research was undertaken to explore the
proportion of adults receiving drugs for NTDs who
were migrants, rather than residents. To this end, a five
percent random sample of the names of adults who
took drugs during the mass distribution in 2007 was
taken from the Ministry of Health registers document-
ing the uptake of drugs in five selected villages: Singla
Central, Dei B, Afhoda, Awulu, and Lwalla.4 This five
percent sample consisted of 50 names; and the names
were then cross-checked with the household register
kept by the local council chairman (LC1) for the village.
To further establish the mobility status of each of the
drug recipients on the list, an endeavour was made to
not only contact the local council chairman but also
friends, neighbours and relatives within the village to try
and find out the various occupations and travel patterns
of each person on the list.
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Methods in Moyo and Adjumani Districts
Fieldwork on NTDs was undertaken for the first time in
Moyo and Adjumani districts in 2008. That is, 103
semi-structured interviews were undertaken in 7 villages
on or close to the River Nile in Adjumani district
(Adjujo, Agiforo, Arra Central, Maaji, Malhewe internal
displacement camp, Ogolo internal displacement camp
and Pamajua) and 72 semi-structured interviews were
undertaken in 5 villages and 2 trading centres in Moyo
district (Olia West, Pakaa West, Pakonira East, Panjala,
Paubu, Dufile, Laropi). These semi-structured interviews
were supplemented with open-ended interviews covering
a range of issues with village drug distributors, district
vector control officers and supporting staff, local healers
and political figureheads. Moreover, research in Moyo
and Adjumani districts benefitted from the fact that one
of the authors, Tim Allen, had undertaken long term
ethnographic fieldwork on health and healing in the
region in the 1980 s and 1990 s [33-38]. This research
involved the acquisition of detailed information about
many aspects of social, political and economic life and
proved enormously helpful when interpreting informa-
tion arising from semi-structured interviews.
Methods in Busia District
Research was undertaken in Lumino sub-county for the
first time between July-August 2009. In addition to par-
ticipant observation fieldwork at landing sites on the
shores of Lake Victoria, open-ended, unstructured
interviews were undertaken with staff representing the
Ministry of Health in Busia District as well as drug dis-
tributors, labourers, fisherfolk, political figureheads, clan
leaders, school teachers, religious leaders etc. Semi-
structured interviews were also undertaken with a 10%
random sample of adults residing in 14 of the 64 villages
that constitute Lumino sub-county. The selected villages
were from five of the six parishes in the sub-county, and
they included a range of villages located by rivers and
Lake Victoria, as well as villages with trading centres
and villages relying almost exclusively on agricultural
production.
Results
Self-reported uptake of drugs among adults
The data presented in this section focuses on self-
reported uptake of drugs among adults in Nebbi, Moyo,
Adjumani and Busia districts. Wherever possible, find-
ings are cross-checked with data recording drug uptake
in Ministry of Health registers. Praziquantel has
been distributed regularly in all four districts for the
treatment of schistosomiasis since at least 2004, and
albendazole has been the frontline treatment for soil-
transmitted helminths. By contrast, ivermectin has been
distributed on an annual basis in Moyo and Adjumani
districts since the early part of 2000 and it has also been
distributed in Panyimur, Nebbi district since August
2008. There were no plans to distribute the drug in
Busia district as lymphatic filariasis and onchocerciasis
are not endemic in this part of the country. Results are
presented on a district by district basis and demonstrate
that self-reported uptake of drugs among adults varies
considerably between and within districts.
Self-reported uptake of drugs in Panyimur sub-county,
Nebbi District
To start with Panyimur: it was possible to use Ministry
of Health registers in Panyimur to gauge the proportion
of adults that were re-treated for schistosomiasis and
soil-transmitted helminths in 2007, compared to 2004
and 2005. This was because the 2004 Ministry of Health
registers provided a detailed record of the names of all
adults and children in each village, irrespective of
whether or not they had received MDA. Semi-structured
interviews were then undertaken with a 10% randomly
selected sample of the adult population, from these reg-
isters, in 15 of the 49 villages that constitute Panyimur
sub-county. To ensure that a broad range of villages in
the sub-county were selected, five villages were selected
from each of the three parishes that make up Panyimur
sub-county. The selected villages in Boro Parish were:
Kaligonzi, Nyakiro, Ayago, Situ and Wankado East. In
Nyakagei Parish, the villages selected were: Dei central,
Adondo, Kimor, Lwala and Opurukojo; and the selected
villages in Ganda Parish were Kulluber, Munyua,
Mukindwa, Singla B and Kidi Achoka.
Table 1 shows that the number of adults receiving
treatment in 2007 (compared to 2004) declined in all
three parishes, with the decline being particularly
marked in Nyakagei and Boro Parishes. In all three
parishes, drug uptake fell short of the target of reaching
75% of the adult population.
Self-reported uptake of drugs in Moyo and Adjumani
Districts
In common with Panyimur sub-county, a semi-struc-
tured interview was undertaken with a 10% randomly
selected sample of the adult population in seven villages
in Adjumani district, and five villages and two trading
centres in Moyo district. All selected villages and trading
Table 1 Self-reported uptake of drugs for schistosomiasis
and soil-transmitted helminths among adults in selected
villages, Panyimur, Uganda
2004 2005 2007
Ganda Parish
N = 148
62% 36% 59%
Nyakagei Parish
N = 192
65% 43% 36%
Boro Parish
N = 255
78% 32% 33%
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centres were located within 2 kilometres of the
River Nile.
With respect to Moyo district, self-reported drug
uptake among adults was variable. Table 2 shows, for
example, that the uptake of drugs in three of the seven
villages was 90% or more in 2008 whilst the other four
villages had an uptake of 50% or less (and the overall
average in Moyo was 55%). The years 2007, 2006 and
2005 also witnessed considerable variation. That is, the
overall uptake of drugs in 2007, 2006 and 2005 was
41%, 39% and 32% respectively, with uptake ranging
from 0-95% in 2007, 8-76% in 2006 and 8-50% in 2005.
In 2007, two out of the seven selected villages reached
or exceeded the target of treating 75% or more of the
adult population.
Results from Adjumani district are more promising,
with overall uptake increasing from 29% in 2005 to 59%
in 2006 and 50% in 2007. In 2008, the reported uptake
increased further to 74%. In common with Moyo dis-
trict, there was considerable variation between selected
villages. That is, the uptake of MDA in 2008 ranged
from 5% to 100%, with 5 of the 7 villages exceeding the
target of 75% uptake among adults. These data are pre-
sented in Table 3. Unfortunately, it was not possible to
use information in the Ministry of Health drug registers
to corroborate or refute these data as the information
had not been recorded in a usable fashion (a point dis-
cussed below).
Self-reported uptake of drugs in Busia District
The analysis of survey data documenting self-reported
uptake of drugs among adults for the treatment of schis-
tosomiasis and soil-transmitted helminths suggests that
64% of those interviewed received praziquantel in 2009
and 67% received the drugs in 2008. The proportion of
adults swallowing the drug under the direct gaze of the
drug distributor was 50% in 2009 and 58% in 2008.
While it proved impossible to acquire detailed informa-
tion on drug uptake prior to 2008, information emer-
ging from semi-structured interviews and key
informants indicated that uptake had fallen in 2008 and
2009 due to increasing food shortages within the dis-
trict, and a reluctance to swallow praziquantel if there
was insufficient food to mitigate the side-effects.
Nevertheless, these data suggest that while the majority
of adults have not received three or more rounds of pra-
ziquantel since 2004, a mere 18% have never received
any treatment. Before discussing explanations for varia-
tions in the uptake of drugs between study sites, it is
important to first reflect on the quality of data assessing
adult responses to MDA.
Interpreting data on the uptake of drugs among adults
At all field sites, it proved extremely difficult to acquire
a detailed understanding of the proportion of the adult
population that had taken praziquantel and/or albenda-
zole and ivermectin in any one year. With the exception
of Panyimur sub-county in 2004 and 2005, the Ministry
of Health registers recorded, on a village by village basis,
the names of all the people that were given the tablets
as well as their ages, height and the number and types
of tablets they were given. Names of all residents in vil-
lages receiving MDA were not entered prior to treat-
ment nor were they entered on a household by
household basis. In the absence of reliable census data,
it is thus impossible to use ‘official’ data to gauge the
proportion of the adult population treated or the pro-
portion of adults re-treated.
A second difficulty concerns the interpretation of data
in the Ministry of Health registers as the mode of distri-
bution has changed over time. Even in Panyimur sub-
county, where there is a possibility of comparing the
proportion of adults that have received treatment at dif-
ferent points in time, it is not straightforward. That is,
drugs were distributed from door to door in 2004 and
2007, and adults were able to take them in their own
time. In 2005, however, villagers had to go to a central
distribution point and swallow the drugs under the
direct gaze of the drug distributors if they wanted to
receive praziquantel and/or albendazole. While a few
exceptions were made, it meant that those recorded in
the drug distribution register as taking the drugs had
actually swallowed them. The same cannot be said for
those recorded in the Ministry of Health registers for
2004 or 2007. In other words, the decline in the uptake
of drugs in 2005 may not be as marked as the official
figures suggest as the uptake of drugs in 2004 and 2007
may be artificially high.
A third difficulty concerns the proliferation of Minis-
try of Health registers. From 2004 to 2007, there were
two sets of registers in circulation: one documented the
uptake of drugs for the treatment of schistosomiasis and
soil-transmitted helminths, while the other documented
the uptake of drugs for lymphatic filariasis and oncho-
cerciasis. In 2008, new ‘integrated treatment’ registers
arrived with a view to monitoring the uptake of drugs
for schistosomiasis, soil-transmitted helminths, lympha-
tic filariasis, onchocerciasis and trachoma. This register
was meant to replace existing registers from July 2007,
Table 2 Self-reported drug uptake as a percentage at
selected villages in Moyo District, 2005-2008
Olia
West
Pakaa
West
Pakonira
East
Panjala Paubu Dufile Laropi
2008 90 50 92 5 100 15 33
2007 0* 17 38 95 17 88 33
2006 50 8 38 32 17 54 76
2005 30 8 38 26 50 46 29
* No reported distribution.
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but it arrived late. This, in itself, created confusion -
with some drug-distributors over-writing the 2007 and
2008 columns with 2008 and 2009 respectively, while
others did not.
In Moyo and Adjumani districts, the situation was
complicated by the fact that the registers documenting
the uptake of drugs for ivermectin and albendazole were
not withdrawn. This generated enormous confusion as
some drug distributors decided to record the names of
those receiving ivermectin in the old Carter Centre/
Ministry of Health registers; while others wrote the
same name in two registers (i.e. the Carter Centre/
Ministry of Health register and the new USAID/RTI/
Ministry of Health register); and still others felt so over-
whelmed by the volume of work that they simply
handed out drugs without recording any information in
either register. Integration of treatment in this respect
has failed as it has led to the collapse of an already
fragile mechanism for MDA accounting. From a research
and monitoring point of view, it renders the official regis-
ters almost useless.
A fourth problem is that the majority of drug distribu-
tors handed out drugs without observing their consump-
tion. This compounds a fifth problem, which concerns
the interpretation of data documenting the uptake of
drugs from semi-structured and open-ended interviews
with MDA recipients. There are several aspects to this,
all of which tend to over-estimate rates of self-reported
drug consumption. It was common at most sites for
those interviewed for the first time to say positive things
about treatment and to ask for more tablets. Yet, some
of these same people would say something rather differ-
ent when interviewed again some days or weeks later. In
Panyimur in 2005, several respondents who had been
very positive about MDA were observed not accepting
the drugs during distributions, or taking them, but
refusing to swallow them. While there is no doubt that
drugs are being distributed at a village level and in sev-
eral studied locations, the majority of adults are being
given the opportunity to take them, it does not follow
that they are being consumed, or consumed in the right
doses. In Panyimur, where the language spoken is Alur,
words for ‘to take’ and ‘to swallow’ are ‘nitingo’ and
‘mwonyo’ respectively, but if you ask the question ‘did
you take the tablets?’ and an informant answers ‘yes,
I took the tablet’, that could mean ‘yes, I took the tablet
and swallowed it’ or ‘yes, I took the tablet, and put them
in my pocket.’
Great efforts were made to clarify what actually hap-
pened, but it was hard to know at what point a really
straightforward answer was being given. Even infor-
mants who came to know the researchers really well
appeared reluctant to say that they had not swallowed
the tablets for fear of either being asked to return them
or being forced to swallow them under the gaze of the
interviewer. Neither would, of course, have happened,
but the fear was palpable, particularly if someone had
experienced side effects in the past. There were numer-
ous occasions when informants eventually admitted that
they had been given the tablets but kept them or taken
the tablets and only swallowed some of the them. The
following comment by a 43 year old woman, living close
to Lake Albert, illustrates this point. She said: “I took
two tablets [but] I have kept the rest for when I fall
sick.”
In Moyo and Adjumani districts, a further difficulty
with interpreting data on the uptake of drugs, is that
increasing numbers of people are not sure what drugs
they are swallowing. Ivermectin is a small, white tablet;
praziquantel is long, white and has two horizontal
marks on it; and albendazole is white, with one horizon-
tal mark on it. It is not quite as long and does not smell
in the way praziquantel smells, but the differences are
subtle and easy to confuse. While every effort was made
to help informants differentiate between these two
tablets, there were numerous occasions when adults
shook their heads, unable to speak with confidence as to
whether they had taken ivermectin and albendazole or
ivermectin and praziquantel or ivermectin, praziquantel
and albendazole. Where this occurred, the method
adopted in this research was to call over neighbours and
to have a collective discussion to help clarify the issue.
Such discussions were usually interesting in themselves
and, in each case, a consensus view was taken on which
drugs had been distributed on which occasion and
whether or not they had been taken by the individual
concerned.
Some adults also struggled to recall the precise year(s)
in which they had received and/or swallowed drugs -
though this was rarely an issue in the northern districts
Table 3 Self-reported drug uptake as a percentage at selected villages in Adjumani District, 2005-2008
Adjujo Agiforo Arra Central Maaji Malehwe IDP* Ogolo IDP Pamajua
2008 89 94 5 81 100 70 79
2007 33 50 53 19 78 86 37
2006 78 39 68 78 33 47 74
2005 22 6 42 37 11 32 58
* Internal Displacement Camp.
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of Nebbi, Moyo and Adjumani as the distribution of
tablets was ‘news’ at all field sites, and the vast majority
of people had clearly discussed whether or not to
receive and/or swallow the relevant tablets with relatives
and friends. In other words, it was not something one
could forget too easily. However, it was more of a pro-
blem in Busia district, south-eastern Uganda where
MDA is one of many programmes run by the govern-
ment and/or NGOs. Again, where there was confusion
about years of distribution, this was resolved in discus-
sion with neighbours and reference to the relevant drug
distribution registers.
In spite of the difficulties in eliciting accurate self
reported information about drug take up, and the need
to triangulate findings with other data wherever they
were available, it is apparent from the findings presented
above that the integrated national programme for NTD
control has heterogeneous effects. To be more specific,
the uptake of drugs among adults is low in Panyimur,
variable in Moyo and Adjumani districts and relatively
high in Busia district. Why? These questions are
addressed, in turn, in the following section.
Discussion
Why is the uptake of drugs among adults low in
Panyimur?
A range of political, economic and social factors influ-
ence the uptake of drugs in Panyimur. These include a
fear of treatment, divergence between local and biome-
dical understandings of NTDs, insufficient and inade-
quate health education, migration patterns, ineffective
systems of drug distribution and the changing political
and economic context in which MDA occurs. These
issues are discussed in turn.
Fear of treatment
In common with 2005, the majority of informants (70%)
throughout the sub-county expressed a fear of treat-
ment. This fear took a variety of forms, including a fear
of side-effects arising from treatment with the drug, pra-
ziquantel; a fear of infertility and/or a fear of death.
A 35 year old male fisherman, for example, said:
“I found my child under a tree ... her clothes covered
in diarrhoea and vomit. Then I hear she has taken
those drugs at school ... aarh! I do not want my chil-
dren to take them next time. I shall not take them
anymore.”
Similarly, a 27 year old male from Sendi village, Panyi-
mur sub-county captured some of these anxieties when
he said: “In Dei, a woman was tall and thin and given
too many drugs. She died so some people fear the
drugs.” This comment was followed by a discussion of
mass treatment in which he mentioned that he had
been given the drugs, praziquantel and albendazole,
three times in 2005, 2006 and 2007. The first time, he
took four tablets in one go and fell ill for two weeks. As
a result he lost his job and he now feels afraid to take
them again. The four tablets he was given in 2007 are
still in his house and he expressed uncertainty as to
whether he should take them. However, he also reported
having pains in his stomach so he was turning over in
his mind the possibility of taking them once he had
planted the cotton, but emphasised that if he took them
then he would only take one tablet at a time, rather
than all four together.
Without a doubt, the occurrence of side-effects
generates confusion and anxiety, and a fear of treatment
contributes to the low uptake of drugs in Panyimur sub-
county. In contrast to 2005, however, informants were
less likely to use these fears to question the intentions
of government and donors. Instead, their questions sug-
gested that at least some adults are becoming accus-
tomed to ‘strong’ drugs. The following quotes illustrate
this point:
“Why are the drugs [praziquantel] weak these days? At
the start [2004], it was strong and had bad side-effects ...
does it mean it is not working anymore?” (53 year old
male from Ganda Parish.)
“This time we did not get any side-effects. It means
the drugs are useless and not working anymore ... other
types of drugs should be brought” (30 year old female
from Singla B, Ganda Parish)
Divergence between local and biomedical understandings
of NTDs
In north-western Uganda, local understandings of
‘bilharzia’ do not mirror biomedical understandings of
‘bilharzia’ and intersects with other local afflictions. In
Panyimur, a local affliction known as ‘awola’ mirrors the
signs and symptoms of those associated with infection
by S.mansoni. In 2005, the diagnosis of awola was often
cited as a reason for rejecting treatment as it was widely
believed that if a person with awola swallowed prazi-
quantel, they would die. By 2008, awola was no longer
so closely associated with the signs and symptoms of
bilharzia and it did not, therefore, impinge on treatment
in the way that it had done previously. Indeed, many
local healers who were interviewed in 2008 said they
had taken the tablets themselves. Also, the local
affliction, awola, became associated with other diseases. It
is impossible to quantify these changes, but it is striking
that none of those interviewed in 2008 stated that a person
with awola would die if they swallowed praziquantel,
whereas this was almost universally asserted in 2005.
Insufficient and inadequate health education
In common with 2005, health education remains inade-
quate. To our knowledge, endeavours to provide infor-
mation about the aetiology of NTDs and the rationale
Parker and Allen Health Research Policy and Systems 2011, 9:3
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for mass treatment is restricted to district staff running
training days with school teachers and drug distributors.
At best, these sessions involve discussing how to admin-
ister the drugs safely, but key questions are not ade-
quately addressed. For instance, why do some people
suffer serious side-effects and other people not suffer
any? Why should people who feel well take the drugs?
Why is it necessary to allocate drugs by height rather
than weight? What is the point of taking the drugs,
when re-infection is likely? What diseases do the drugs
treat? How do biomedical understandings of the aetiol-
ogy and treatment for NTDs relate to local understand-
ings and therapies for these diseases? It would be really
helpful to address these questions, especially as the
majority of adults do not perceive bilharzia (S.mansoni)
and soil-transmitted helminths to be major health pro-
blems. Malaria, HIV/AIDS, poisoning and witchcraft are
thought to be much more serious. In fact, the absence
of information about the rationale for mass treatment
has fuelled conspiracy theories.
A further problem with existing health education is
that some of the materials used are confusing. One
striking example is that posters relating to schistoso-
miasis show a person standing in water. A worm is
shown next to this individual’s heal in a circle. This is
supposed to convey, through the gaze of a microscope,
cercariae penetrating a foot. This is assumed rather
than explained and it is all the more confusing as the
foot is not magnified. As a result, the picture looks as
though something like an earthworm is about to wig-
gle its way into the body. A similar image is used on
the cover of the drug distributors’ register. Not sur-
prisingly a typical response by those who see the pic-
ture is: “we don’t have worms like that!” Confusion is
compounded by the fact that the primary school
science textbook describes bilharzia, but only gives
information about S.haematobium. In addition, the
health education messages relating to soil-transmitted
helminths refer to ‘worms’, and do not adequately dis-
tinguish between different kinds of worms. Teachers
and drug distributors are expected to understand the
health education message well enough to communicate
the distinctions, but this was rarely found to be the
case in practice. These issues were noted in 2005, and
raised with district and national officials. No change
was evident three years later.
It goes without saying that it would be helpful to
improve the quality of health education materials, but it
is also the case that health education alone will not be
enough to reverse the fortunes of the programme. There
are several reasons why this is the case, including the
regular movement of large numbers of people across the
border of Congo and, to a lesser extent, Sudan; and on-
going difficulties with relying upon volunteers to
distribute drugs with minimal recompense. These two
issues are discussed in turn.
Migration patterns
Panyimur sub-county shares an international border
with the Congo and the movement of Congolese and
Ugandans across the border has had a profound influ-
ence on the take-up of drugs. There is no empirical data
documenting the number of people moving across the
border, but participant observation in Panyimur Trading
Centre revealed that kin relations between Alur residing
in Uganda and Congo are strong and inter-connected
with substantial trading networks. Indeed, Flynn [39]
has recently argued that the Alur, whether Ugandan or
Congolese, perceive their identity as Alur as being much
more significant than their nationality.
It is against this backdrop that hundreds of people
travel from Congo to Panyimur to attend the weekly
Monday market. Others come from Sudan (usually by
truck) and a variety of places within Uganda, including
the districts of Hoima, Masindi, Buliisa, Moyo, and Kit-
gum. They buy and sell fish, grain and other produce,
and many of them arrive the night before and sleep in
the open air, with those from Congo sleeping close to
the landing sites on the shores of Lake Albert. The 10
public latrines available in the Trading Centre cannot
possibly cater for the number of people arriving and
there is little doubt that the regular influx of large num-
bers of people does little to hinder the transmission of
schistosomiasis and soil-transmitted helminths.
Against this background, an endeavour was made to
calculate the proportion of adults receiving drugs for
NTDs who were residents rather than migrants. Such
calculations are complex as enquiries quickly revealed
that it is not always straightforward classifying someone
as ‘resident’ or ‘mobile’, not least because many people
who are resident in a particular village do not register
with the local council. Figure 1 shows, for example, that
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Figure 1 Percentage of Drug Recipients in the Household
Register Source: Adapted from Rees, [48]: 27).
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less than a third of the actual residents in Dei B, a small
village close to the border with Congo, were recorded in
the household register.
However, for the purposes of this research, a ‘mobile
person’ was defined as anyone who travelled regularly,
whether for one or two nights a week or one or two
months a year. Figure 2 shows that a large proportion of
the population were classified as mobile, with the village,
Singla Central, having the highest proportion (46%) of
mobile people receiving drugs. This is not surprising as
the market is located in this village and large numbers
of people trade here every Monday. Dei B had the sec-
ond highest proportion of mobile people (33%) taking
the drugs. The village is located on the Congolese bor-
der and adults frequently cross the border to buy and
exchange goods. Several informants also commented on
the fact that Congolese people were known to come to
Dei during mass treatment programmes to take the
drugs back to their country. In fact, one 18 year old tra-
der who comes from the Congo to trade in the market
every week said:
’We get [the drugs] in Dei ....We come here to buy
because we can’t get them in Congo ... I know some-
one who collects the balance of drugs after mass
treatment. They hear over the radio there is going to
be mass treatment, so they come’
The proportion of mobile ‘adults’ receiving drugs for
NTDs was 30%, 28% and 24% in the villages of Lwalla,
Afhoda and Awulu respectively. Almost certainly, this is
due to the fact that these villages are located further
away from the border with Congo.
The influx of migrants at times of drug distribution
and, in accord with government policy, the willingness
of drug distributors to provide the drugs to such people
(many of whom are close relatives who live on the
Congolese side of the border) explains why the number
of drugs distributed in Panyimur is high, but does not
reach all of the locally resident population. In several vil-
lages, more than half of the surveyed households did not
receive drugs in 2007. The ramifications of this are signif-
icant: high rates of re-infection for S.mansoni were
recorded by SCI in primary schools in the sub-county.
That is, re-infection rates of 76% and 90% were recorded
among school children attending Panyimur Primary
Schoool and Nyakagei Primary School in 2008 respec-
tively; and there is every reason to suppose that re-
infection will continue unabated until the issue is
addressed. A further difficulty concerns the reliance upon
unpaid drug distributors, to which attention now turns.
On-going difficulties with voluntary distribution
The National Control Programme for the Integrated
Treatment of NTDs relies upon volunteers to distribute
drugs to adults within their ‘community’. This approach
assumes that communities are cohesive and that drug
distributors have both the time and inclination to
undertake the required tasks. Research in Panyimur
highlighted the hazards of this approach. These include
the following: first, the majority of drug distributors said
they felt ‘too poor’ to work without remuneration. The
following quotes capture this point:
“There is no incentive to work .. there are no uni-
forms, no bicycles for transport.”
“We are not paid ... we cannot work well ... I have
firewood to gather [from the hills], water to collect
[from the lake] and six children to feed. It is too far to
walk to a homestead that is 2 or 3 kilometres away at
the end of the day.”
“I shall give the tablets out, but refuse to register them
.. that is the right option for me because the Ministry of
Health have money but they refuse to release it.”
District officials echoed these concerns, albeit in a dif-
ferent way. To quote:
“They [the drug distributors] are running out of
patience ... I am worried for the next round of treatment ...
ah, this sitting allowance is very little.”
“The spirit of volunteerism has gone completely ...
they are not realising the benefits.”
A second difficulty is that the channels for distributing
drugs overlooks gender relations and assumes that the
benefits of free treatment over-ride other concerns. This
is not the case. Participant observation fieldwork with
young, female drug distributors, for example, revealed
that it is impossible for a woman to insist that an older
man swallows his praziquantel tablets (or any other
tablets) under her gaze. In all cases, the men concerned
put the tablets in their pocket, to be taken at a time of
their choosing.
Third, the rationale for the provision of free treatment
on a regular basis has not been communicated to drug
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distributors in a convincing way. As a result, they are
not able to answer questions and concerns expressed by
those who are meant to be swallowing the tablets.
These include the following: ‘why is it necessary to take
praziquantel if you feel well?’; ‘is praziquantel for pre-
vention or cure?’; ‘why are tablets being allocated by
height rather than weight?’; ‘what is the point of taking
praziquantel if re-infection is almost immediate?’; ‘why
is it necessary for someone to take praziquantel if they
do not have any sign of infection?’
Are there prospects of drug uptake in Panyimur improving?
In spite of on-going concerns about side-effects, inaccu-
rate and ineffective health education, migration, and the
current system of relying upon voluntary drug distribu-
tors, there were some indications that drug uptake may
improve over time, without external intervention. This
is because villagers are making their own empirical
observations of the benefits of treatment. By way of
illustration, a 59 year old male from Kidi Achoka,
Ganda Parish described how he had a swollen stomach
since the 1980 s but feared to take the drugs. Then, in
2005, he was drunk and decided to swallow them. He
had serious vomiting, skin rashes for two weeks and he
ended up going to hospital. Here, the doctor told him
that he was suffering from the side-effects of the tablets
rather than from a bad sickness. He subsequently
became fit and strong. To quote:
“I used to suffer from blood in the stool and abdom-
inal pain before I started taking the drugs, but after
2005, I feel I am relieved from that pain because I no
longer suffer from these illnesses ... this is why I cannot
deviate or hesitate from taking those drugs.”
Thus findings in 2008 suggested that there were
grounds for optimism, albeit small, as conspiracy the-
ories were less prevalent, and political and economic
changes occurring at a national and district level were
beginning to positively affect day to day life in Panyi-
mur. Nevertheless, few people are willing to swallow
tablets if they feel they have insufficient food to mitigate
the side-effects and these small changes cannot be equa-
ted with the emergence of a demand for treatment.
The changing political and economic context
The generally poor levels of adult drug uptake in Panyi-
mur and slight improvement noted in 2008 also need to
be understood in relation to political and economic
developments in the area. In 2005, life in Panyimur was
affected by insecurity. Sandwiched between the uphea-
vals in the Democratic Republic of Congo and the on-
going war between the Ugandan government and the
Lords’ Resistance Army [LRA] to the east, economic
activity was thwarted. The situation was exacerbated by
a lack of rain; dwindling fish stocks in Lake Albert;
receding forests; and an apparent disinterest on the part
of the government to invest in services and
infrastructure. Indeed, these concerns contributed to
widespread complaints about the government deliber-
ately pursuing policies to ensure that the Alur, (the
dominant ethnic group in Panyimur), remained poor
and marginal. Resentment against the government was
frequently expressed in terms of a north/south divide
within the country and concerns about side-effects aris-
ing from treatment with praziquantel were on numerous
occasions explicitly linked with accusations about gov-
ernment officials wanting to reduce the rate of popula-
tion growth in the district. Such views were not just
expressed in private, but also at focus group discussions
and public gatherings.
However, considerable change occurred after 2005.
Some of the most important include the following: a tar-
mac road running from Karuma to Pakwach was com-
pleted in 2007. This had a quick and beneficial impact
on the economy at a district level, and this was visible
in Panyimur (which is about 45 minutes drive away
from Pakwach). Diesel, for example, is now for sale in
Panyimur and there are increasing credit opportunities
for local people, with district officials in Nebbi town
even borrowing from local micro-finance groups in
Panyimur. Some of these changes are also linked to the
government making a concerted effort to gain political
support in the district during the Presidential election
campaign of 2005-2006. This paid off as they secured
47% of the votes - in contrast to their nearest rival, the
Forum for Democratic Change, which secured 43% of
the vote. Panyimur’s sub-county’s local council chairman
(known as LC3) is now the ruling party’s chosen candi-
date to become the next local council chairman for
Nebbi district (LC5). Although various local tensions
remain, notably with respect to the activities of soldiers
and police on market days, general attitudes towards the
government have become much more positive. One
consequence of this shift in attitude was that in 2008
the provision of drugs through government structures
was treated with less suspicion than was the case in
2005. Rainfall was also good that year, and food supplies
not as scarce. In addition, the LRA retreated into south-
ern Sudan and the relative stability this afforded was
welcomed. These changes in Panyimur corresponded
with improved responses to drug take up among some
of those interviewed, although other problems noted
above remained. Also, in 2009 the rains were poor and
issues of food scarcity resurfaced. Expectations have
been raised about the projected local benefits of oil dis-
coveries in and around Lake Albert, but this has also led
to a dramatic rise in the value of land. Concerns and
complaints about government officials, especially at dis-
trict level, are again expressed quite widely, and ongoing
drug distribution in mid 2009 showed every sign of
again achieving low uptake rates.
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Why is MDA acceptable in Moyo and Adjumani districts,
and why does the uptake of drugs among adults vary so
much between locations within the districts?
The uptake of drugs for the treatment of bilharzia and
soil-transmitted helminths was higher at selected sites in
Adjumani and Moyo districts compared to Panyimur,
Nebbi district. This finding is particularly interesting as
the proportion of informants reporting side-effects was
not markedly less (65% and 68% compared to 70%).
Differences in the mode of drug delivery could not be
discerned nor was any greater effort made at communi-
cating ideas about appropriate treatments for NTDs to
local council chairmen, drug distributors and villagers.
Although impossible to quantify, it is likely that differ-
ences in the take up of drugs in these nearby areas of
north-western Uganda can be attributed to historical
differences, while wide variations in self-reported uptake
between sites within the districts can largely be
explained by more recent events.
Both Moyo and Adjumani districts are predominantly
populated by Madi people and historical research sug-
gests that the Madi might be particularly amenable to
the roll out of MDA, at least compared to other parts of
north-western Uganda. Briefly, for most of the Protecto-
rate period, Moyo and Adjumani districts were adminis-
tered as Madi sub-district and were designated as a
closed location. This meant that movement into and out
of the sub-district was controlled. Even labour migration
to the south of the district was restricted. There were
two reasons for this: first, in the early years of the Pro-
tectorate administration, Madi sub-district was perceived
by the British administration as a place affected by revo-
lutionary Islam. It had been the location of Mahdist
forts in the nineteenth century, heavily affected by slav-
ery and ivory trading. Until the 1920 s, much of the
local administration took place through chiefs in Arabic.
A concerted attempt was made to reverse such trends
and Italian missionaries were actively encouraged to
promote Catholicism. This proved to be a remarkably
successful strategy and Catholicism became a powerful
force. In fact, church sermons remain profoundly influ-
ential in shaping ideas about moral probity. This relates
directly to health care in that the church has persistently
challenged ‘pagan’ beliefs, and promoted ideas about
physical wellbeing that sets aside ideas about ancestral
spirits in preference to biomedical therapies.
A second reason for keeping Madi sub-district a
closed area was because it was seen as an epicentre for
the spread of sleeping sickness. From the 1920 s, large
parts of the population were moved and re-settled close
to roads and administrative locations. In fact, popula-
tions inhabiting tsetse infested bush zones (such as in
Lefore to the west of Moyo town and swathes of Adju-
mani district to the south of Adjumani town) were
forcibly removed. Sleeping sickness control measures
remained in force throughout the protectorate period
and were re-introduced in the 1980 s following the
return of thousands of Madi from Sudan (where they
had fled first the fighting in Uganda and subsequently
the fighting in Sudan). In collaboration with interna-
tional agencies such as Medecins Sans Frontier, the
Ugandan government introduced a mass testing and
treatment programme in the late 1980 s, which had the
effect of reversing a rising prevalence rate. To a large
extent, other mass treatment programmes such as
immunization campaigns have been affected by this his-
tory of successful disease control and have elicited a
positive response from the population.
An effect of these policies was that by the end of the
Protectorate period, the Madi were perceived by British
officials as a uniquely malleable and responsive popula-
tion, with a willingness to collaborate fully in public
policies. They were also perceived as having a remark-
able commitment to education. To a large extent, this
legacy has survived the political turmoil following inde-
pendence. Although Moyo and Adjumani district have
been affected by these problems, it is striking that while
certain Madis have been active in political life, Madi
people as a whole have tended to be accepting of gov-
ernment authority, irrespective of the nature of the gov-
ernment in power. As in Panyimur, it is common to
hear complaints about being “the forgotten people,” but
the kinds of conspiracy theories that circulate in other
locations in the north are largely absent. Indeed, district
officials, local vector control staff and other community
leaders would often emphasise this point, stating that
whereas at other locations people are always telling stor-
ies about how certain kinds of drugs are introduced for
allegedly pernicious purposes (such as to secretly control
the population), this is rarely the case in Moyo and
Adjumani districts.
The positive response by the Madi to MDA in Moyo
and Adjumani districts can be attributed to the follow-
ing: first, the Catholic Church is very influential and
actively supports a range of public health initiatives
such as immunization programmes, child health days
and endeavours to control NTDs. As a result, there is
widespread enthusiasm for MDA. Second, the long his-
tory of disease control in this part of Uganda, notably
the mass treatment programmes that were instigated
to contain and control sleeping sickness, dating back
to the Protectorate period. In contrast to Panyimur,
there was no question of MDA being actively resisted.
The following quote captures the willingness of Madi
throughout Adjumani to receive free drugs for the
treatment of bilharzia (schistosomiasis), filaria
(lymphatic filariasis) and other worms (including soil-
transmitted helminths):
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“I have never heard of people refusing the tablets ... I
was told to buy the drug after testing positive [for bil-
harzia] but I could not afford them so I took the ones
distributed to my home ... I don’t know the name of the
drug,” (a 25 year old male from Ogolo IDP camp.)
Even people who were aware of the side-effects
expressed a willingness to receive free treatment. Thus,
a 76 year old male from Melehwe IDP camp said: “Peo-
ple say that when it disturbs you it means you have the
worms and you should continue with the tablets so that
the worms can reduce in the body.”
Similarly, a 45 year old female from a different IDP
camp in Adjumani district who took praziquantel in
2006 and 2007 with side-effects said: “I will continue to
take it until I die;” and a 20 year old male from Ogollo
IDP camp who reported taking praziquantel five times
said: “some say it makes you feel drunk and can make
you mad.” Such talk did not deter him from taking the
drugs.
There were, however, considerable differences in self
reported drug take-up between sites in the two districts.
To a large extent that is explained by the effects of inse-
curity and the responses to the needs of displaced popu-
lations. In recent years, Adjumani and Moyo districts
have been more directly affected by warfare than the
population of Panyimur in Nebbi district. In 2008, for
example, many parts of Moyo and Adjumani districts
were affected by the presence of large numbers of Suda-
nese refugees, and the World Food Programme were
providing food relief to the local population as well as
Sudanese refugees. Primary schools at all the sites where
research occurred in Moyo and Adjumani districts, for
example, were assisted by a school feeding programme.
This was still continuing in 2008 but was about to be
terminated as many Sudanese were being repatriated as
part of the Sudanese Comprehensive Peace Agreement.
The districts have also been affected by the insecurity of
surrounding areas and occasionally by incursions by a
variety of military forces. The new road between the riv-
erine locations of Laropi and Dufile running up the
Metu mountains to Moyo town remains partially fin-
ished as one of the Chinese workers was killed in an
attack by the LRA. In Adjumani district, which is unpro-
tected by the River Nile, and located on one of the main
LRA routes into the war zone of northern Uganda, the
population has been particularly vulnerable. Indeed, one
of the last LRA attacks inside Uganda occurred in the
displacement camp at Ogolo in 2006. Much of the
population of Eastern Adjumani district had been con-
centrated in this camp, located very close to the Sudan
border and in sight of the Sudanese town, Nimule. For a
large number of the residents, this has meant a shift
from an inland location to one close to the Nile. It is
for this reason that it was chosen as one of the fieldsites.
High uptake was recorded in both Ogollo and
Malehwe internal displacement camps in 2007 and
2008. Life is highly regulated in these camps, with clear
rules and regulations enforcing many aspects of social
life. The concentration of large numbers of people into
a relatively small space makes it relatively straightfor-
ward for drug distributors to distribute drugs, and MDA
occurs in a context where international assistance from
a range of donors is welcomed and trusted. Indeed,
many would not be able to survive without such assis-
tance. Similarly, the lower rates of drug uptake recorded
in 2005 and 2006 reflect the fact that life was greatly
affected by the political and economic insecurity gener-
ated by the movement of the LRA. Many of those who
accepted the drugs in 2007 and 2008 were simply not
offered the drugs in 2005 and 2006.
A further reason for variations in self-reported drug
take up relate to widespread knowledge of side-effects.
The fact that a need to eat before swallowing praziquan-
tel is well known has meant that the uptake of drugs has
been greatly influenced by the activities of the World
Food Programme. In 2007, food was widely distributed
to Sudanese refugees as well as Ugandan Madi accom-
modating them in their villages (notably Adjujo and
Arraa central.) The repatriation of Sudanese refugees in
March 2009 led to the withdrawal of the World Food
Programme to Sudan. As a result, the uptake of drugs
among school children and adults dropped at several
locations as teachers were not willing to distribute drugs
in the absence of food and adults were similarly not
willing to swallow them.
In Arra Central, for example, drug uptake fell to 5% in
2008 as large numbers of Madi refused to accept treat-
ment without food. It should also be added that there
were serious shortages of food in Adjumani and Moyo
between July and September 2009 as international agen-
cies were buying up food in these two districts to distri-
bute in Sudan. Consequently, food that would otherwise
have been for sale in Ugandan markets was no longer
present. The spiralling cost of food in northern Uganda
is generating considerable hunger - though it was
beyond the remit of this research to verify this observa-
tion empirically.
It is important to note that self-reported uptake of
drugs exceeds those documented in the NTD Ministry
of Health registers and, almost certainly, is much more
accurate. There are two reasons for this: first, the system
for monitoring the distribution of drugs has effectively
broken down with the introduction of the ‘new’ NTD
registers in 2007/8. That is, community drug distribu-
tors, feel completely confused by the fact that there are
now two registers in circulation: one for monitoring the
distribution of ivermectin and albendazole for the treat-
ment of lymphatic filariasis and onchocerciasis and one
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for monitoring the distribution of all NTD drugs includ-
ing ivermectin and albendazole. Unsure as to whether
they should copy the names of people receiving iver-
mectin and albendazole from the lymphatic filariasis/
onchocerciasis register into the ‘new’ NTD register,
when they are only receiving one round of ivermectin
and albendazole a year, they end up writing down the
names of only a few of those who actually receive treat-
ment and there is an element of serendipity as to
whether the names recorded go in the ‘old’ lymphatic
filariasis/onchocerciasis register or the ‘new’ NTD regis-
ter. Second, population figures reported to the district
have been persistently exaggerated, often by as much as
three times the actual population. This persistent exag-
geration has the explicit aim of securing additional food
aid, but it also means that it is unhelpful to gauge the
proportion of the people receiving MDA by comparing
the number of people recorded as taking drugs for
NTDs with census data held at the district level.
Why has control of NTDs been apparently successful in
Busia district?
The political, economic and social context of treatment
in Busia district differs markedly from that outlined for
north-western Uganda. It is located at the opposite end
of the country from the other research sites, in a region
that has benefitted substantially from the relatively high
economic growth of Uganda since the late 1980 s.
Although there have been border tensions with Kenya
and also violent incidents at times of elections, the area
has not been directly affected by armed insurgencies or
refugee influxes. The district has attracted substantial
private and governmental investment, and its location at
the most busy border crossing with Kenya, Uganda’s
most economically successful neighbour, as well as its
ready accessibility from Kampala, has given it a different
national visibility and political significance to areas of
the northwest. Indeed, it is frequently held up by gov-
ernment officials as a model district, with a committed
local administration and a place where public health
programmes are run effectively.
Significantly, in 2009, a large new fish processing plant
in Lumino sub-county was operating close to the lake
shore, and a high grade landing site and market was
being constructed nearby. A tarmac road was about to
be constructed, linking these projects with Busia town.
A new bridge and road was also planned, giving more
direct access to the main highway to Kenya. These
initiatives were being implemented at the same time as
new public health policies aimed at cleaning up the dis-
trict, and regulating access to the lake were being
enforced. The implications of these initiatives are dis-
cussed further on.
Of all the districts studied in Uganda, Busia was found
to be the most successful at NTD control. This can be
partially explained by the relatively high take up and
consumption of tablets. However, it is not the whole
story. In common with the Madi and Alur of north-wes-
tern Uganda, it was found that few of those interviewed
had much understanding of how infections with bilhar-
zia and other kinds of parasitic worms occurred. Here,
as in the northwest of Uganda, infection with ‘bilharzia’
is generally connected with water sources in a vague
way, and almost everyone mentioned the drinking of
dirty water. So a reported decline in infection from
S.mansoni by the Ugandan Ministry of Health does not
correlate with better local knowledge. Instead, as with
the north-western part of the country, political and
economic changes shed light on the situation.
Busia is widely perceived as a ‘model’ district, and the
government has a visible and active presence within the
district. The security of the new fish processing plant in
Lumino sub-county is being managed by a private
security firm; and this firm, closely associated with the
Beach Management Unit, is helping to regulate access
to the lake. In 2007, for example, more than 3/4 of
registered fisherman had their licenses revoked and fish-
ing in the vicinity of the landing sites is now tightly con-
trolled by the Beach Management Unit. This has
significantly reduced the number of people accessing the
lake on a regular basis, but it has also had ramifications
for the population as a whole as large numbers of adults
used to be involved, if not in fishing, then fish proces-
sing and/or the provision of services to fishermen at
landing sites. Although it was impossible to acquire
detailed empirical data in the time available, long-stand-
ing residents noted that the total number of people liv-
ing close to the landing sites had dropped dramatically
in recent years.
Running alongside a commitment to clean up beach
landing sites and the lake shore more generally, public
health acts have been used to enforce hygiene beha-
viours. These include the enforcement of a 5,000 shilling
fine for any household that does not have a pit latrine,
as well as a 5,000 shilling fine for anyone caught urinat-
ing or defecating in the lake and a 3,000 shilling fine for
anyone caught bathing in the water.
A further difference to the scenarios described in
Panyimur, Nebbi district and Moyo and Adjumani dis-
tricts, is that food is generally available. This means that
those taking praziquantel are generally doing so after
eating, reducing the risks of serious side effects. The
occurrence of relatively minor side-effects, alongside the
visible presence of the state attempting to improve
roads, develop ‘ecological’ fishing etc has undoubtedly
contributed to the prevailing view that the mass
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distribution of drugs by district health staff is beneficial
to local people.
While it is impossible to assess the extent to which
the decline in S.mansoni infection is the result of MDA
rather than the imposition of public health acts restrict-
ing access to the lake, it is also important to note that
there have been serious consequences for the neigh-
bouring district, Bugiri. Research carried out in 2009
suggests that Busia has to some extent passed the diffi-
culties of controlling NTDs to other areas. Findings on
self-reported uptake of praziquantel and albendazole
among adults from Banda and Sigulu sub-counties of
Bugiri indicate that 34% received these drugs in 2008
and 43% received these drugs in 2007. These figures are
based on a 10% sample of randomly selected households
from 5 villages in Banda sub-county and 5 villages in
Sigulu sub-county. The selected villages in Sigulu sub-
county were located on Sigulu and Lolwe islands, the
former being 40 minutes from the mainland and the lat-
ter being 2 hours and 40 minutes by boat from the
mainland. There has been no MDA in 2009 and limited
MDA in 2008 as the district vector control officer has
been seriously ill for 18 months and no effective repla-
cement has been found. As a result, only 13 of the 39
villages received MDA in 2008.
Ugandan Ministry of Health data documenting the
prevalence of S.mansoni in Bugiri district suggested
that in 2007 the prevalence was 46%. It is not at all
clear what type of impact MDA may have had on the
prevalence of infection, but it is unlikely to have been
as effective as in Busia district. This is not only due to
the relatively low coverage of MDA, but also to the
fact that 18 of the 39 villages in Bugiri district are
located on the lake shore and water and sanitation
facilities are very limited (in part because the soil is
often too light to support pit latrines and the water
from bore holes is too salty to drink). In addition, no
attempt has been made to enforce by-laws that inter-
rupt transmission. In Sigulu sub-county, there are 142
inhabited islands with logistical and budgetary reasons
often being cited as explanations for the dearth of
MDA. These need to be overcome as 98% adults in
the sub-county reported that they had not received any
treatment in the last two years and some of those that
had received treatment had had to pay local councils
for the drugs. Investigation of the clinic on the biggest
island Sigulu, revealed that there were 5 unopened tins
of praziquantel, suggesting that the picture is much
more complex than overcoming logistics and budgetary
constraints. Census data is hard to come by, but there
is clearly considerable migration into the area. At one
landing site on Lolwe Island, for example, it was
reported that the number of registered fisherfolk had
increased from 328 to around 1000 following the
restrictions imposed in Busia district.
In sum, there is nothing particularly remarkable about
drug delivery strategies in Lumino sub-county, Busia
district and self-reported uptake is not as high as in
parts of Adjumani and Moyo district. Drug distributors,
whilst willing to take the time to distribute drugs, are
not exceptionally well motivated. Registers are poorly
kept and there is no endeavour to ensure that drugs are
always swallowed. However, the low recorded prevalence
of S.mansoni demonstrates that a political agenda to
develop ‘ecological’ fishing, in combination with a will-
ingness to enforce public health acts, to ensure that
Busia sustains its reputation as a flagship district has
played a major role in contributing to the decline in
prevalence.
Conclusions
The comparative study of drug uptake in three districts
in north-western Uganda and two districts in south-
eastern Uganda has highlighted the differential uptake of
drugs between districts as well as variations within dis-
tricts over time. Insights emerging from ethnographic
research are used to interpret quantitative data on drug
uptake as well as parasitological data detailing the preva-
lence and intensity of infection. In so doing, it has
become clear that a single policy formulated by the
World Health Organisation, in consultation with advi-
sors from London, Seattle, Washington and staff from
the Ministry of Health in Uganda, cannot be rolled out
in a uniform way across the country; and it will inevita-
bly be influenced by the political, economic, historic and
social context in which it occurs. This, in turn, affects
responses to MDA as well as rates of re-infection. The
implications of this finding are wide-ranging and they
are discussed below.
Before doing so, it is important to draw attention to
the point that the data presented in this paper suggest
that a large majority of adults at field sites in north-
western and parts of south-eastern Uganda have had the
opportunity to receive drugs, free of charge, for schisto-
somiasis and soil-transmitted helminths since 2004. In
some districts, such as Adjumani, reported take-up in
particular years was very high, and most adults will have
had the opportunity to take treatment on that occasion.
Elsewhere, such as parts of Nebbi District, no single
distribution in any given year reached a similarly high
percentage, but almost every long-term resident inter-
viewed had been offered treatment at least once.
Although not a primary focus of our research in
Uganda, this was also the case where treatment was
investigated for lymphatic filariasis and onchocerciasis.
While coverage has not reached the targets initially
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planned for high take up of repeated treatments, this is
still a considerable achievement.
To move forward from this point necessitates lessons
being learned from what has worked and what has
failed. It requires the kind of information reported in
this paper. Points arising from the findings include the
following. First, there is a need to put in place an ade-
quate system for monitoring as the programme cannot
run effectively without identifying difficulties quickly
and easily. Relying upon volunteers to keep a detailed
record of drug uptake year on year, whilst simulta-
neously increasing their work load with minimal remu-
neration, is generating large quantities of inaccurate
data. Opportunities are being missed by not collecting
and analysing robust information about drug uptake and
relating this to systematic assessments of disease preva-
lence and intensity of infection.
Second, these problems are exacerbated by the fact
that USAID/RTI currently fund and take primary
responsibility for implementing the integrated NTD pro-
gramme. It is run as a parallel structure located within
the Ministry of Health, with rounds of funding linked to
‘successful’ implementation. ‘Off the record’, many of
those involved with MDA are well aware that there are
difficulties with the programme, but fear that the publi-
cation of more objective evaluations will lead to the
withdrawal of funding and free drugs, rather than a bet-
ter programme. They find themselves in an impossible
position.
Third, at all research sites, health education is poor
and where it does occur, it assumes that people only
need selective information. As a result, local under-
standings of the transmission of parasitic infections are
confused and information about appropriate health-
seeking behaviours is muddled. For example, it is very
common for people to attribute bilharzia to the fact that
they might not have washed their hands before eating
or that they did not boil the water before drinking it. In
Panyimur sub-county, the limited and inaccurate health
education materials fuelled conspiracy theories. Health
education needs to address local concerns and anxieties.
It is not just a question of producing new and more
detailed booklets, though this is needed too as a matter
of urgency.
Fourth, it would be helpful for district officials to
enforce existing public health acts. If successes reported
in Busia district provide an example to follow, it is
surely that transmission can be reduced by using exist-
ing legislation to regulate behaviour - including the
imposition of fines for not having a pit latrine and defe-
cating by or in the infected water, and possibly limiting
access to certain rivers and lakes.
Fifth, it would be fair to say that MDA has not yet
generated a demand for treatment. While there are a
few places where adults are articulating a desire for
treatment (notably in villages along the River Nile in
Moyo district); and while there were a few individuals at
some of the other research sites articulating a demand
treatment; the majority of adults in targeted areas are
not pressurising district authorities and medical person-
nel for a continuous supply of tablets. In addition, there
is no evidence to suggest that they will be willing to buy
the medicines themselves once MDA comes to an end.
It is hard to see how a demand for treatment can
emerge as there is so much confusion about the ratio-
nale for MDA at all the research sites. Conspiracy the-
ories in Uganda have not snowballed in the way that
they have in Tanzania, where violent riots characterised
local response to MDA in some locations in 2008.5
Nevertheless, they exist at all sites, and in some of the
distributions studied have impinged upon drug take-up.
Local concerns about the rationale for MDA clearly
need to be addressed more adequately than they are at
present.
The findings presented in this paper resonate with
those reported by anthropologists working on other ver-
tical interventions linked to the Millenium Development
Goals health objectives, such as immunization coverage
in West Africa [40-42] and the control of tuberculosis
in Nepal [43]. More specifically, it remains to be asked
how much can be generalised from the findings pre-
sented here on schistosomiasis and soil-transmitted hel-
minths in Uganda; and what type of insights emerge by
comparing local responses to the treatment of these dis-
eases with treatment for other NTDs.
As has been highlighted above, there is a paucity of
evidence with which to answer these questions.
Recently, Kabatereine has reported that MDA has con-
tributed to the eradication of onchocerciasis at some
locations in Uganda, that S.haematobium may also be
eradicated soon, and lymphatic filariasis is on track for
elimination by 2020 (Kabatereine, personal communica-
tion in October, 2010). These are encouraging observa-
tions, but it would be valuable to investigate what has
been achieved in detail at the local level, not least
because Katabarawa and colleagues drew attention to
problems arising in onchocerciasis control at their
Ugandan research sites in the 1990 s [16,17]. Also,
research undertaken by Parker, Allen and Hastings on
the roll out of MDA in Tanzania for S.haematobium,
S.mansoni, lymphatic filariasis, soil transmitted hel-
minths and onchocerciasis suggests that comparable
issues have arisen to those observed in Uganda with
respect to S.mansoni. These include a tendency to per-
sistently overstate drug uptake which at some locations
was found to be very low indeed (see Hastings [44] and
M Parker and T Allen ‘social responses to mass drug
administration in northern coastal Tanzania’, report
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submitted to the SCI, Imperial College, London, April
2008). Research on a number of different NTDs in Tan-
zania additionally raises a point that has not been dis-
cussed explicitly with respect to Uganda, but would
have emerged more clearly if MDA for a similar range
of infections had been studied - namely, that NTDs are
not experienced as a homogenous category of infections
and it is misleading to treat them as if they are.
Information presented here has related primarily to
S.mansoni and soil-transmitted helminths, but most of
the problems highlighted relate to the control of the for-
mer rather than the latter. To a large extent this is con-
nected with the subjective perceptions of those being
treated. Everyone interviewed recognised that a human
being - or a domestic animal - could be infected with
worms. The worms can sometimes be seen in the stool.
It is also known that certain kinds of local and manufac-
tured medicines result in a purging of worms from the
body. This, too, is directly connected with experience of
having watched it happen. By contrast, S.mansoni,
requires a person who is likely to think he or she is
healthy accepting the idea that it is possible to be
infected without feeling ill. This, in itself, contradicts
health care messages about taking drugs without a
proper diagnosis. It also requires a large degree of trust
in those delivering treatment and confidence that they
know what they are doing. In many situations, such
trust and confidence is lacking.
Research carried out in Tanzania has found a similar
difficulty with respect to lymphatic filariasis. Here, too, a
leap of faith is required by those on the receiving end of
MDA as it is important to be treated before symptoms
become manifest. Infection with S.haematobium, on the
other hand, is often characterised by the visible symp-
tom of reddy-brown urine among children and young
adults. As a result, there was widespread recognition in
some locations that treatment might be necessary. How-
ever, this was not found to be the case at all study sites.
In these places, the fact that the symptom of bloody
urine is not present in most infected adults was linked
to a perception that it is a harmless condition - one that
only affects children, and which they grow out of it even
if they remain untreated. This, in turn, fuelled scepti-
cism and conspiracy theories about why free treatment
was being offered. Lack of communication by those dis-
tributing tablets - and specifically inadequate explana-
tions for why school children were being made to take
tablets at school by their teachers - was a primary cause
of the above mentioned riots in 2008.
None of this means that the MDA approach cannot
work as, in some places, it already has. But, as things
stand, international assistance and funding has too
many strings attached. It is being spent too quickly and
it is as likely to weaken health systems as it is to
strengthen them. It is surely unrealistic to assume that a
vertical programme, delivered through mechanisms that
are effectively separate from those developed within gov-
ernment ministries and poorly informed about local cir-
cumstances, will improve the long-term health of
populations that, for the most part, are politically and
economically marginal. There are reasons why these
people have tended to be overlooked and why they may
distrust the motivations of those instructing them to
take tablets. Those reasons cannot just be wished away.
There is a requirement for a serious rethink, including
more sensible and more closely evaluated targets, and,
above all, responses that are sensitively tuned to particu-
lar circumstances. To persist with the current “one size
fits all” approach is to fail those most in need of
assistance.
Appendix
1Considerable emphasis was placed upon the need to
create a demand for treatment in the early years of the
programme. It is re-iterated in the recent process eva-
luation of Schistosomiasis Control published by staff
from SCI, Imperial College and the Ugandan Ministry of
Health. To quote: ‘It was intended that the initial sup-
port from SCI would reduce the disease burden asso-
ciated with helminth infection and provide districts with
experience in controlling disease, thereby creating a
demand for treatment and sustainable government
financial and political support’ [[32]:1].
2 This focus was due to our link with SCI, Imperial
College and the Vector Control Division, Ministry of
Health, Uganda. In addition, schistosomiasis has been a
long-standing research interest of one of the authors (see,
for example, Parker [45]; Parker [46] and Parker [47].)
3 This paper is based upon fieldwork funded by the
Bill and Melinda Gates Foundation as part of a grant to
SCI, Imperial College. London. Ethical clearance was
passed by the ethics committee of Imperial College for
surveillance and monitoring activities for the evaluation
of national control programmes for the control of
NTDs. We worked closely with staff from the Ministry
of Health, Uganda and obtained additional research
clearance at a national and district level.
4 The five selected villages were chosen to capture the
variety of villages in the sub-county. Singla Central is
the most densely populated trading area within Panyi-
mur as the market is located here and attracts visitors
from Sudan, the Democratic Republic of Congo, and
Kenya. Dei B is located at the border between Uganda
and the Democratic Republic of Congo. Here, it is inter-
esting to note that children living close to the border in
Congo cross the border every day to go to primary
school in Nyakagei Parish, Panyimur. Afhoda lies to the
west of Singla Central whereas Awulu is located near
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the shores of Lake Albert between Singla Central and
Dei B and Lwalla is located in the hills rising up from
the lake.
5 These events were closely observed by one of our
PhD students, Julie Hastings, who had to be rescued
from her field research site by Tanzanian police [44].
The events were reported in the Tanzanian media, and
have led to retrenchment in some of the Tanzanian
MDA operations.
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